Exact Mass: 440.023

Exact Mass Matches: 440.023

Found 13 metabolites which its exact mass value is equals to given mass value 440.023, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Ceftezole

8-oxo-7-[2-(1H-1,2,3,4-tetrazol-1-yl)acetamido]-3-[(1,3,4-thiadiazol-2-ylsulfanyl)methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C13H12N8O4S3 (440.0144)


   

Binimetinib

5-[(4-Bromo-2-fluorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-1,3-benzodiazole-6-carboximidate

C17H15BrF2N4O3 (440.0296)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EE - Mitogen-activated protein kinase (mek) inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C69145 - Mitogen-Activated Protein Kinase Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor

   

Tembotrione

Tembotrione

C17H16ClF3O6S (440.0308)


CONFIDENCE standard compound; INTERNAL_ID 339; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4471; ORIGINAL_PRECURSOR_SCAN_NO 4470 CONFIDENCE standard compound; INTERNAL_ID 339; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4415; ORIGINAL_PRECURSOR_SCAN_NO 4410 CONFIDENCE standard compound; INTERNAL_ID 339; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4505; ORIGINAL_PRECURSOR_SCAN_NO 4504 CONFIDENCE standard compound; INTERNAL_ID 339; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4421; ORIGINAL_PRECURSOR_SCAN_NO 4419 CONFIDENCE standard compound; INTERNAL_ID 339; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4503; ORIGINAL_PRECURSOR_SCAN_NO 4501 CONFIDENCE standard compound; INTERNAL_ID 339; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4477; ORIGINAL_PRECURSOR_SCAN_NO 4476 CONFIDENCE standard compound; EAWAG_UCHEM_ID 3177

   
   

BIS(ETHYLCYCLOPENTADIENYL)TUNGSTEN DICHLORIDE

BIS(ETHYLCYCLOPENTADIENYL)TUNGSTEN DICHLORIDE

C14H18Cl2W (440.0295)


   

(2R)-2-Deoxy-2-fluoro-2-methyl-D-erythro-pentonic acid-g-lactone 3,5-bis(4-chlorobenzoate)

(2R)-2-Deoxy-2-fluoro-2-methyl-D-erythro-pentonic acid-g-lactone 3,5-bis(4-chlorobenzoate)

C20H15Cl2FO6 (440.023)


   

thiamine thiazolone pyrophosphate

thiamine thiazolone pyrophosphate

C12H18N4O8P2S (440.0321)


   

Ceftezole

Ceftezole

C13H12N8O4S3 (440.0144)


J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DB - First-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   

di-tert-butylsilyl bis(trifluoromethanesulfonate)

di-tert-butylsilyl bis(trifluoromethanesulfonate)

C10H18F6O6S2Si (440.0218)


   

Binimetinib

MEK162(ARRY-162,ARRY-438162)

C17H15BrF2N4O3 (440.0296)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EE - Mitogen-activated protein kinase (mek) inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C69145 - Mitogen-Activated Protein Kinase Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor

   

methyl (4s,5e,7s)-14,14-dibromo-7-hydroxy-4-methoxytetradeca-5,13-dienoate

methyl (4s,5e,7s)-14,14-dibromo-7-hydroxy-4-methoxytetradeca-5,13-dienoate

C16H26Br2O4 (440.0198)


   

methyl (4s,5e,7r)-14,14-dibromo-7-hydroxy-4-methoxytetradeca-5,13-dienoate

methyl (4s,5e,7r)-14,14-dibromo-7-hydroxy-4-methoxytetradeca-5,13-dienoate

C16H26Br2O4 (440.0198)


   

methyl 14,14-dibromo-7-hydroxy-4-methoxytetradeca-5,13-dienoate

methyl 14,14-dibromo-7-hydroxy-4-methoxytetradeca-5,13-dienoate

C16H26Br2O4 (440.0198)